There is no evidence to expand the use of uric acid lowering drugs beyond current indications for gout or nephrolithiasis, according to a comprehensive review of the evidence. The ‘umbrella review’ comprised 144 meta-analyses of observational studies, 32 meta-analyses of randomised controlled trials and 107 Mendelian randomisation analyses. The findings should put to bed any lingering suspicions ...
Umbrella review clears fogginess abound uric acid
By Mardi Chapman
27 Jul 2017